Core Viewpoint - The company, 凯因科技, expects a significant decline in net profit for 2025, primarily due to substantial asset impairment and the withdrawal of drug registration applications [1] Financial Performance - The projected net profit attributable to the parent company for 2025 is estimated to be between 26 million to 38 million yuan, representing a year-on-year decrease of 73.31% to 81.74% [1] - The expected non-recurring net profit for 2025 is forecasted to be between 20 million to 30 million yuan, reflecting a year-on-year decline of 78.10% to 85.40% [1] - For 2024, the net profit attributable to the parent company is reported to be 142.3692 million yuan [1] Reasons for Performance Change - The primary reasons for the performance change include the recognition of large asset impairments and the proactive withdrawal of drug registration applications, leading to full impairment provisions [1] - Excluding these impacts, the net profit for 2025 is expected to remain stable compared to the previous year, indicating steady development in the core business [1]
凯因科技:2025年净利润预减73.31% - 81.74%,营收未提及